TriSalus Life Sciences, Inc (TLSI) insider trading
Every open-market stock purchase and sale by TriSalus Life Sciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Richard Marshak (C-suite exec) and 2 others sold $4.1K in the last 90 days.
- Last insider buy: Michael P Stansky (Director), $1M, 5 months ago.
Last 12 months: insiders bought $3.6M (10 buys) and sold $140K (9 sales). Last close $3.66 on Oct 22, 2026.
Recent TLSI insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 5, 2026 | Mary T Szela (CEO) | Sold (not open market) | $11.8K |
| Oct 5, 2026 | Richard Marshak (C-suite exec) | Sold | $1.4K |
| Oct 5, 2026 | Jennifer Stevens (C-suite exec) | Sold | $1.4K |
| Oct 5, 2026 | Bryan F. Cox (Officer) | Sold | $1.3K |
| Jul 1, 2026 | David Patience (CFO) | Sold (not open market) | $65.3K |
| Jun 30, 2026 | Mary T Szela (CEO) | Bought (not open market) | $15.4K |
| Jun 30, 2026 | Richard Marshak (C-suite exec) | Bought (not open market) | $2.2K |
| Jun 29, 2026 | Richard Henry Marshall (C-suite exec) | Bought (not open market) | — |
| Jun 29, 2026 | Richard Henry Marshall (C-suite exec) | Bought (not open market) | — |
| May 15, 2026 | Michael P Stansky (Director) | Bought | $1M |
| May 15, 2026 | Michael P Stansky (Director) | Bought | $500K |
| May 15, 2026 | Mats Wahlstrom (Director) | Bought | $152K |
| May 15, 2026 | Mary T Szela (CEO) | Bought | $103K |
| May 15, 2026 | Gary B. Gordon (Director) | Bought | $24.6K |
| May 15, 2026 | David Patience (CFO) | Bought | $17.3K |
| May 15, 2026 | Richard Marshak (C-suite exec) | Sold | $1.4K |
| May 14, 2026 | William Valle (Director) | Bought (not open market) | — |
| May 14, 2026 | William Valle (Director) | Bought (not open market) | — |
| May 14, 2026 | Gary B. Gordon (Director) | Bought (not open market) | — |
| May 14, 2026 | Gary B. Gordon (Director) | Bought (not open market) | — |
| May 14, 2026 | Gary B. Gordon (Director) | Bought (not open market) | — |
| May 14, 2026 | Kerry R Hicks (Director) | Bought (not open market) | — |
| May 14, 2026 | Kerry R Hicks (Director) | Bought (not open market) | — |
| May 14, 2026 | David J Matlin (Director) | Bought (not open market) | — |
| May 14, 2026 | David J Matlin (Director) | Bought (not open market) | — |
Who's trading TLSI
- Bryan F. Cox, Officer: sold $14.4K (4 sales), last Oct 5, 2026
- Mary T Szela, CEO: bought $228K (2 buys), sold $79.4K (2 sales), last Oct 5, 2026
- Richard Marshak, C-suite exec: sold $17.1K (5 sales), last Oct 5, 2026
- Jennifer Stevens, C-suite exec: sold $15.9K (4 sales), last Oct 5, 2026
- David Patience, CFO: bought $32.2K (2 buys), last Jul 1, 2026
- Richard Henry Marshall, C-suite exec: other filings, last Jun 29, 2026
- Michael P Stansky, Director: bought $3M (4 buys), last May 15, 2026
- Gary B. Gordon, Director: bought $64.6K (2 buys), last May 15, 2026
- Mats Wahlstrom, Insider: bought $152K (1 buy), last May 15, 2026
- Kerry R Hicks, Director: other filings, last May 14, 2026
- William Valle, Director: bought $125K (1 buy), last May 14, 2026
- David J Matlin, Director: other filings, last May 14, 2026
- Jodi Devlin, Officer: sold $13.2K (3 sales), last Mar 16, 2026
Get free alerts when an insider at TriSalus Life Sciences, Inc files a new trade →